Oxford–AstraZeneca COVID-19 vaccine

Viral vector vaccine for prevention of COVID-19 by Oxford University and AstraZeneca

Oxford–AstraZeneca COVID-19 vaccine    ▸ Facts   ▸ Comments   ▸ News   ▸ Videos   

Oxford–AstraZeneca COVID-19 vaccine: Viral vector vaccine for prevention of COVID-19 by Oxford University and AstraZeneca
The Oxford–AstraZeneca COVID-19 vaccine, codenamed AZD1222, and sold under the brand names Covishield and Vaxzevria among others, is a viral vector vaccine for prevention of COVID-19. Developed in the United Kingdom by the Oxford University and British-Swedish company AstraZeneca, it is given by intramuscular injection, using as a vector the modified chimpanzee adenovirus ChAdOx1. Studies carried out in 2020 showed that the efficacy of the vaccine is 76.0% at preventing symptomatic COVID-19 beginning at 22 days following the first dose and 81.3% after the second dose. A study in Scotland found that, for symptomatic COVID-19 infection after the second dose, the vaccine is 81% effective against the Alpha variant, and 61% against the Delta variant.

UK revises travel policy, implies issue is India's vaccine certificate | Covishield | Oneindia News [Video]

UK revises travel policy, implies issue is India's vaccine certificate | Covishield | Oneindia News

The UK has revised its travel policy to include Covishield as an approved vaccine after a furious India warned of ‘reciprocal measures’, but Indians double-vaccinated with the shot still have to..

Credit: Oneindia     Duration: 01:40Published
India to retaliate against new jab policy of United Kingdom for travelers | Oneindia News [Video]

India to retaliate against new jab policy of United Kingdom for travelers | Oneindia News

The new jab policy by the United Kingdom has raised issue in India. India threatened to retaliate against new British travel rules putting those who are vaccinated with Covishield in the category of..

Credit: Oneindia     Duration: 01:52Published
PM promotes Covid jab to sceptical Brazilian president [Video]

PM promotes Covid jab to sceptical Brazilian president

Boris Johnson has hailed the UK's AstraZeneca Covid jab as a "great vaccine" during a meeting with Brazilian president Jair Bolsonaro, who has previously shared vaccine-sceptic views. The prime..

Credit: ODN     Duration: 01:21Published
Joe Biden urges Afghan leaders to fight against Taliban | Withdrawing US troops | Oneindia News [Video]

Joe Biden urges Afghan leaders to fight against Taliban | Withdrawing US troops | Oneindia News

US President Joe Biden urged Afghanistan’s leaders to fight for their homeland; Today, Lok Sabha was adjourned indefinitely today, bringing an end to the tumultuous Monsoon session of Parliament;..

Credit: Oneindia     Duration: 02:26Published
ICMR study suggests mixing Covaxin and Covishield can work better against Covid-19 | Oneindia News [Video]

ICMR study suggests mixing Covaxin and Covishield can work better against Covid-19 | Oneindia News

According to a study by the Indian Council of Medical Research, mixing and matching of the Covid-19 vaccines available in India that are Covaxin and Covishield have shown better results in building..

Credit: Oneindia     Duration: 01:17Published

Creator of Oxford vaccine made into Barbie doll [Video]

Creator of Oxford vaccine made into Barbie doll

Professor Dame Sarah Gilbert has been honoured as a ‘Barbie Role Model’ for her work creating the Oxford vaccine.It is hoped the Barbie doll will inspire girls to consider a career in science.

Credit: PA - Press Association STUDIO     Duration: 01:07Published
Rahul Gandhi on nine-year-old girl's rape: Dalit child nation's daughter too| Oneindia News [Video]

Rahul Gandhi on nine-year-old girl's rape: Dalit child nation's daughter too| Oneindia News

Top political leaders today expressed anguish over the allegedrape and murderof a nine-year-old Dalit girl in the Delhi Cantonment area on Sunday. The government has said today that the pandemic is..

Credit: Oneindia     Duration: 03:00Published

You Might Like

No change in Covishield dose gap: NTAGI chief

Dr N K Arora, chairman of the Covid-19 working group of National Technical Advisory Group on Immunisation (NTAGI), on Saturday ruled out any changes in the gap between two doses of Covishield citing..
IndiaTimes - Published

Italy recognises Covishield; travellers jabbed in India eligible for Green Pass: Indian embassy in Rome

Italy has become the latest EU member to recognise WHO-approved Covishield, after several others like Germany, Switzerland, France and Spain. Indian vaccine card holders are now eligible for GreenPass,..
IndiaTimes - Published

No technical concern in Covishield certificate process, says UK in sign of conciliation

IndiaTimes - Published

Covishield: Neither side raised concerns with each other’s certification process, says UK envoy

IndiaTimes - Published

Centre files plea against allowing second dose of Covishield earlier, says it will derail policy

IndiaTimes - Published

Covishield approved in UK, travel advisory revised after strong objections from India

The UK has revised its vaccine policy for travelers from India, and Covishield jabs have been approved in the travel advisory.
DNA - Published

India warns UK of reciprocal steps over vaccine ‘discrimination’

“Covishield is a licensed product of the UK company, manufactured in India of which we have supplied five million doses to the UK,” said Shringla, pointing to the inconsistency in the rules..
IndiaTimes - Published

India says UK govt's stand on Covishield 'discriminatory', warns of 'reciprocal action'

IndiaTimes - Published

Faceoff: UK's non-recognition of Covishield creates storm on Twitter

The UK government’s new international travel rules putting those who are vaccinated with Covishield in the category of the 'unvaccinated' have been blasted as "offensive", "bizarre" and "racist".
IndiaTimes - Published

India to protest against new UK vaccine travel rules not recognising Covishield

External Affairs Minister S Jaishankar is likely to speak to the newly-appointed British Foreign Secretary Liz Truss on UK not recognising Covishield.
DNA - Published

Centre places purchase order with Serum Institute for 66 crore Covishield doses to be supplied by Dec: Sources

IndiaTimes - Published

Allow second Covishield dose after 4 weeks from first for those who want it early: Kerala HC to Centre

IndiaTimes - Published

Covishield, Covaxin & Sputnik V: You can now identify COVID-19 fake vaccines with these steps

India is currently administering 3 vaccines - Covidshield, Covaxin and Sputnik V. Here are some ways in which you can identify if the vaccine is fake
DNA - Published

84 days gap between Covishield vaccine doses provides best protection against COVID-19: Centre

The duration of 84 days between first and second doses of the Covishield COVID-19 vaccine gives the best protection against coronavirus, Centre said
DNA - Published

Fake Covishield doses in Southeast Asia, Africa: UP govt issues alert to all DMs, CMOs

The Uttar Pradesh government has issued an alert after fake Covishield doses were found in Southeast Asia and Africa.
DNA - Published

No plan yet to revise Covishield dose gap, clarifies govt

IndiaTimes - Published

Government mulls reducing time gap between Covishield doses, say sources

IndiaTimes - Published

Majority Indians experienced no or mild side effects post 2 doses of Covishield and Covaxin: Report

IndiaTimes - Published

COVID-19: Gap between two doses of Covishield may be reduced

At present, over 59 crore vaccine doses have been administered in the country and efforts are being made by the government to expedite the process.
DNA - Published

84-day gap in Covishield doses due to efficacy or availability? Kerala HC asks Centre

Justice PB Suresh Kumar said that if efficacy was the reason, he was "worried" as he got the second dose within four-six weeks of the first dose.
DNA - Published

Kerala man files plea in court for Covishield after taking both doses of Covaxin, read why

The man Girikumar, 50 had filed a plea in the Kerala High Court stating that he works in Saudi Arabia which is yet to recognise the Covaxin.
DNA - Published

DCGI gives nod to conduct study on mixing Covaxin, Covishield

The Drugs Controller General of India (DCGI) has given approval to conduct a study on mixing Covaxin and Covishield vaccines. The research study will be done by Christian Medical College, Vellore, said..
IndiaTimes - Published

Permission granted to CMC Vellore to mix vaccine doses for research study: Dr V K Paul

DCGI has approved a proposal from the CMC Vellore to carry out trials on the mixed use of COVID-19 vaccines, Covishield and Covaxin in people.
DNA - Published

Covishield-Covaxin mix offers better shield, says ICMR study

The study examined 18 individuals in UP who inadvertently received Covishield as the first jab and Covaxin as the second. "The findings suggest that immunisation with a combination of an adenovirus..
IndiaTimes - Published

136 crore Covishield, Covaxin doses to lead India's vaccination drive during August-December

More than 136 crore Covid-19 vaccine doses are expected to be available till the end of this year, informed the Centre. For the next four months, India's vaccine programme will be accelerated by the..
IndiaTimes - Published

Government likely to reduce Covishield dose gap but are you eligible? Find answer

The decision to increase the gap of dosage to 12-16 weeks was met with criticism as the move was interpreted as an attempt to manage vaccine scarcity.
DNA - Published

CDSCO expert panel recommends nod to study on mixing doses of Covaxin, Covishield

An expert panel of India's central drug authority on Thursday recommended granting permission to the Christian Medical College (CMC) in Vellore for conducting a clinical trial of mixing of two Covid-19..
IndiaTimes - Published

Covishield generates 93% protection, says AFMC study

Covishield generated 93% protection against Covid, whereas mortality due to the infection came down by 98% during the second wave which was driven by Delta variant, officials said citing a vaccine..
IndiaTimes - Published

Covishield reduces fresh infections by 93%, deaths by 98%: AFMS study

A study by Armed Forces Medical Services (AFMS) has found that Covishield vaccine reduces fresh COVID-19 infections by 93 per cent and deaths by 98 per cent, the Defence Ministry said on Tuesday.
IndiaTimes - Published

NTAGI recommendation to increase gap between Covishield doses based on scientific evidence: Govt

The recommendation of an expert panel on Covid to increase the gap between Covishield doses was made based on scientific evidence in a transparent manner, the government informed Rajya Sabha on..
IndiaTimes - Published

France accepts travellers vaccinated with India's manufactured Covishield - Check full list of countries

The European Union only recognises AstraZeneca manufactured vaccines as a certificate for COVID-19 travel
DNA - Published

17 European nations have given nod to Covishield: Serum Institute of India

IndiaTimes - Published

15 of 27 member countries of the EU have approved Covishield: Poonawalla

IndiaTimes - Published

No application received from SII for EU authorisation of Covishield vaccine: EMA

Poonawalla last month said that he was 'taking this up at the highest levels with regulators and diplomats' and that he hoped to resolve this matter.
DNA - Published Also reported by •IndiaTimes

Government buying Covishield at Rs 215, Covaxin at Rs 225

The fresh vaccine orders placed by the Centre are at a revised price of Rs 215 for Covishield and Rs 225 for a dose of Covaxin, according to an official source. “We are on path to achieving the..
IndiaTimes - Published

Government orders 66 crore vaccine doses worth Rs 14,505 crore

The government is placing its largest order yet of Covid vaccines at 66 crore doses worth Rs 14,505 crore to procure Covishield and Covaxin shots that will help it to substantially meet the vaccine..
IndiaTimes - Published

Switzerland, Iceland, 7 EU nations approve Covishield for travel entry

Switzerland, Iceland and seven EU countries have approved Covishield, the AstraZeneca vaccine manufactured by Serum Institute of India, a day after India threatened to put European visitors under..
IndiaTimes - Published

India's request to EU: Consider Covishield, Covaxin under 'Green passport' scheme or face reciprocal policy

Controversy unfolded over EU's move to not include India's Covishield and Covaxin under its 'Green Passport' scheme for its Digital COVID Certificate.
DNA - Published

Adar Poonawalla says EU green pass Covishield issue has been ‘blown out of proportion’

Serum Institute of India CEO Adar Poonawalla played down on Wednesday Covishield not getting approved for the EU green pass, saying, "It is not a controversy at all. It’s been blown out of..
IndiaTimes - Published

Won't recognise your vaccine certificates if you don't include Covaxin, Covishield: India to EU

India will not recognise EU’s digital covid certificate until the EU includes Indian vaccines Covishield and Covaxin in the certificate. ​​In what is certainly the first diplomatic retaliatory..
IndiaTimes - Published

'Matter of time': SII's Poonawalla confident of getting EU green pass for Covishield

Serum Institute of India (SII) CEO Adar Poonawalla on Wednesday said that the European approval for its locally manufactured Covishield vaccine is "just a matter of time" and is expected in about a..
IndiaTimes - Published

Indians in a fix, Jaishankar raises green pass for Covishield with EU

IndiaTimes - Published

Covishield becomes collateral damage in inter-EU tussle over Chinese vaccines

EMA has listed 4 vaccines, which are Comirnaty (Pfizer), Janssen, Spikevax (previously COVID-19 Vaccine Moderna), and AstraZeneca's Vaxzevria.
DNA - Published

India expands vaccine kitty: Moderna gets regulatory nod; Pfizer approval likely soon

India on Tuesday cleared the decks for the import of Moderna's Covid vaccine, adding another option to its list of anti-Covid shots. Moderna's vaccine, developed in the United States, will be the..
IndiaTimes - Published

Cipla gets DCGI nod to import Moderna's Covid vaccine for restricted emergency use in India: Sources

India's drug regulator DCGI has granted permission to Mumbai-based pharmaceutical company Cipla to import Moderna's Covid-19 vaccine for restricted emergency use in the country, official sources said..
IndiaTimes - Published

France 'actively working' on Indian concerns over Covishield's absence on EU Green Pass

For market authorization of Covishield for use in the EU, the SII needs to apply for EMA, which then conducts a verification of the production site.
DNA - Published

EU agency clarifies on Covishield nod

IndiaTimes - Published

Covishield not a ‘green pass’, Europe-bound Indians fret

BENGALURU: The exclusion of Covishield, AstraZeneca’s Covid-19 vaccine manufactured by Pune-based Serum Institute of India, from the European Union’s Covid ‘Green Pass’ has left hundreds of..
IndiaTimes - Published

SII seeks govt help for adding Covishield in EU vax passport list

IndiaTimes - Published

Approval to Covishield would be considered should we receive marketing authorisation application: EU agency

The Covishield vaccine "does not currently have a marketing authorisation" in Europe and the matter would be considered when an application is received for it, the European Medicines Agency (EMA) said..
IndiaTimes - Published

 Page 1  〉